DAL vs TXMD · P/E 12, rev $61.64B vs rev $1.8M
Delta Air Lines Inc (DAL) versus TherapeuticsMD Inc (TXMD) — a side-by-side from cached financials, not a winner call.
Delta Air Lines Inc (DAL) is a airlines company listed on US. It is led by Ed Bastian.
TherapeuticsMD Inc (TXMD) is a drug manufacturers - specialty & generic company listed on US.
Latest reported DAL revenue for 2024-12-31 was $61.64B. Net income was $3.46B. Revenue was up 6.2% from 2023-12-31 to 2024-12-31. DAL currently screens at market cap $52.18B and trailing P/E 11.6.
Latest reported TXMD revenue for 2024-12-31 was $1.8M. Net income was -$2.2M. Revenue was up 35.3% from 2023-12-31 to 2024-12-31. TXMD currently screens at market cap $13.7M.
DAL currently screens at market cap $52.18B and trailing P/E 11.6. TXMD currently screens at market cap $13.7M.
Not investment advice. Open the DAL and TXMD stock pages for the full models.
Not investment advice.